Cardiovascular magnetic resonance imaging-derived intraventricular pressure gradients in ST-segment elevation myocardial infarction: a long-term follow-up study
Lara S F Konijnenberg, C. Beijnink, Maarten van Lieshout, J. L. Vos, L. Rodwell, V. Bodí, José T Ortiz-Pérez, Niels van Royen, J. R. Rodríguez Palomares, R. Nijveldt
{"title":"Cardiovascular magnetic resonance imaging-derived intraventricular pressure gradients in ST-segment elevation myocardial infarction: a long-term follow-up study","authors":"Lara S F Konijnenberg, C. Beijnink, Maarten van Lieshout, J. L. Vos, L. Rodwell, V. Bodí, José T Ortiz-Pérez, Niels van Royen, J. R. Rodríguez Palomares, R. Nijveldt","doi":"10.1093/ehjimp/qyae009","DOIUrl":null,"url":null,"abstract":"\n \n \n Recently, novel post-processing tools have become available that measure intraventricular pressure gradients (IVPG) on routinely obtained long-axis cine cardiac magnetic resonance (CMR) images. IVPGs provide a comprehensive overview of both systolic and diastolic left ventricular (LV) function. Whether IVPGs are associated with clinical outcome after ST-elevation myocardial infarction (STEMI) is currently unknown. Here, we investigated the association between CMR-derived LV-IVPGs and major adverse cardiovascular events (MACE) in a large reperfused STEMI cohort with long-term outcome.\n \n \n \n In this prospectively enrolled multicentre cohort study, 307 patients underwent CMR within 14 days after first STEMI. LV-IVPGs (from apex-to-base) were estimated on the long-axis cine images. During a median follow-up of 9.7 [5.9-12.5] years, MACE (i.e., composite of cardiovascular death and de novo heart failure hospitalisation) occurred in 49 patients (16.0%). These patients had larger infarcts, more often microvascular injury and impaired LV-IVPGs. In univariable Cox regression, overall LV-IVPG was significantly associated with MACE and remained significantly associated after adjustment for common clinical risk factors (HR 0.873, 95% CI 0.794-0.961, p = 0.005) and myocardial injury parameters (HR 0.906, 95% CI 0.825-0.995, p = 0.038). However, adjusted for LV ejection fraction and LV global longitudinal strain, overall LV-IVPG does not provide additional prognostic information (HR 0.959, 95% CI 0.866-1.063, p = 0.426).\n \n \n \n Early after STEMI, CMR-derived LV-IVPGs are univariably associated with MACE and this association remains significant after adjustment for common clinical risk factors and measures of infarct severity. However, LV-IVPGs do not add prognostic value to LV ejection fraction and LV global longitudinal strain.\n","PeriodicalId":508944,"journal":{"name":"European Heart Journal - Imaging Methods and Practice","volume":" 77","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal - Imaging Methods and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjimp/qyae009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Recently, novel post-processing tools have become available that measure intraventricular pressure gradients (IVPG) on routinely obtained long-axis cine cardiac magnetic resonance (CMR) images. IVPGs provide a comprehensive overview of both systolic and diastolic left ventricular (LV) function. Whether IVPGs are associated with clinical outcome after ST-elevation myocardial infarction (STEMI) is currently unknown. Here, we investigated the association between CMR-derived LV-IVPGs and major adverse cardiovascular events (MACE) in a large reperfused STEMI cohort with long-term outcome.
In this prospectively enrolled multicentre cohort study, 307 patients underwent CMR within 14 days after first STEMI. LV-IVPGs (from apex-to-base) were estimated on the long-axis cine images. During a median follow-up of 9.7 [5.9-12.5] years, MACE (i.e., composite of cardiovascular death and de novo heart failure hospitalisation) occurred in 49 patients (16.0%). These patients had larger infarcts, more often microvascular injury and impaired LV-IVPGs. In univariable Cox regression, overall LV-IVPG was significantly associated with MACE and remained significantly associated after adjustment for common clinical risk factors (HR 0.873, 95% CI 0.794-0.961, p = 0.005) and myocardial injury parameters (HR 0.906, 95% CI 0.825-0.995, p = 0.038). However, adjusted for LV ejection fraction and LV global longitudinal strain, overall LV-IVPG does not provide additional prognostic information (HR 0.959, 95% CI 0.866-1.063, p = 0.426).
Early after STEMI, CMR-derived LV-IVPGs are univariably associated with MACE and this association remains significant after adjustment for common clinical risk factors and measures of infarct severity. However, LV-IVPGs do not add prognostic value to LV ejection fraction and LV global longitudinal strain.